Holen Sie sich die Stockscreener-App
19.23
6.18%
1.12
Vorhandelsmarkt:
19.23
Schlusskurs vom Vortag:
$18.11
Offen:
$18.2
24-Stunden-Volumen:
597.26K
Relative Volume:
1.52
Marktkapitalisierung:
$1.07B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+6.89%
1M Leistung:
+26.51%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$18.09
$19.43
1-Wochen-Bereich:
$17.25
$19.43
52-Wochen-Spanne:
$14.14
$24.99
Omada Health Inc Stock (OMDA) Company Profile
Firmenname
Omada Health Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie OMDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMDA
Omada Health Inc
|
19.23 | 1.02B | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
285.20 | 45.64B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
61.08 | 9.68B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
97.41 | 8.32B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
59.38 | 11.63B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.57 | 6.57B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omada Health Inc Stock (OMDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-01 | Eingeleitet | Barclays | Overweight |
| 2025-07-01 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-01 | Eingeleitet | Evercore ISI | Outperform |
| 2025-07-01 | Eingeleitet | Goldman | Buy |
| 2025-07-01 | Eingeleitet | JP Morgan | Overweight |
| 2025-07-01 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-07-01 | Eingeleitet | Needham | Buy |
Alle ansehen
Omada Health Inc Aktie (OMDA) Neueste Nachrichten
Health Coach Market is evolving rapidly Through 2025 To 2032 | Noom, Inc., HealthifyMe, Omada Health - openPR.com
Digital Therapeutics for Diabetes Market is projected to reach - openPR.com
Omada Health: A Buy Rating for a Company with Strong Distribution Partnerships and Clinical Validation - AInvest
Omada Health: Long Growth Runway Ahead - Seeking Alpha
Omada Health Sets Q2 Earnings Date: Virtual Healthcare Leader Reports August 7 - Stock Titan
Interleukin Inhibitors Market Generated Opportunities, Future Scope by 2032 | Noom, Inc., HealthifyMe, Omada Health - openPR.com
Omada Health, Inc.: A Promising Buy Amid Technical Weakness and Growth Potential - TipRanks
IPO market remains 'sluggish' despite recent San Francisco listings - The Business Journals
EQBK issues 1.73M shares, completes NBC merger & adds new director | OMDA SEC FilingForm 4 - Stock Titan
More than $16B in med-tech funding raised through 1H25 - BioWorld MedTech
The Making of Omada Health | Omada Health Co-Founder & CEO Sean Duffy - iHeart
Omada Health IPO signals healthier market, avoids ‘down-round’ trend - MSN
Omada Health (NASDAQ:OMDA) Earns Buy Rating from Analysts at Needham & Company LLC - MarketBeat
Omada Health Stock (OMDA): A Growth Story in Digital Health - Value The Markets
Omada Health stock initiated with Buy rating at Freedom Broker - Investing.com
Needham initiates coverage on Omada Health stock with Buy rating By Investing.com - Investing.com India
Omada Health initiated with a Buy at Needham - TipRanks
Omada Health initiated with an Overweight at Morgan Stanley - TipRanks
Omada Health initiated with an Overweight at Barclays - TipRanks
Don’t expect a wave of digital health IPOs quite yet - Modern Healthcare
Omada Health initiated with an Overweight at JPMorgan - TipRanks
Omada Health initiated with a Buy at Goldman Sachs - TipRanks
JPMorgan Issues Buy Rating for Omada Health, Inc. Citing Growth Potential in Underpenetrated $135 Billion Market and Strategic Partnerships - TipRanks
Canaccord Genuity Initiates Omada Health at Buy With $27 Price Target - MarketScreener
Omada Health: Strong Growth Prospects and Path to Profitability with Undervalued Potential - TipRanks
The long-awaited digital health IPO is back, but most late-stage healthcare startups aren't ready for it, according to bankers - Business Insider
What VCs Have Learned About Health Tech in the Public Markets - MedCity News
Omada Health prices IPO at $19 a share, raises $150M - MSN
Health Coach Market Is Booming So Rapidly 2025-2032 -Noom, Inc., HealthifyMe, Omada Health, Inc., Iora Health - openPR.com
Omada Health releases new data on its GLP-1 companion program - Yahoo Finance
New Data: Omada Health GLP-1 Program Doubles Weight Loss Success vs Standard Care - Stock Titan
Digital Therapeutics Market: Opportunities in Mental Health - openPR.com
Omada Health (NASDAQ:OMDA) Upgraded to Hold at Wall Street Zen - Defense World
Digital Musculoskeletal (MSK) Care Market Is Booming So Rapidly - openPR.com
Should You Buy Omada Health Stock After the OMDA IPO? - MSN
Omada Health Prices $150M IPO In-Line With Estimated Range - MSN
Omada & Hinge’s IPO Debuts Signal Success for Digital Health Market, Experts Say - MedCity News
Should You Buy Omada Health Stock After The OMDA IPO? - Barchart.com
Why Omada Health is resisting an AI takeover after its IPO - Business Insider
Healthcare Deals This Week: Omada, Antares, Amplify - Law360
Omada Health IPO debuts with $150m fundraise - Healthcare Brew
The "get-rich-slow business" of digital health - Axios
Smart Healthcare Is Taking Over. Here's Where the Money's Headed - Finansavisen
Omada Health’s Wei-Li Shao to target GPTs, GLP-1s following IPO - Modern Healthcare
Omada Health's Wei-Li Shao to target GPTs, GLP-1s following IPO - Modern Healthcare
Omada, Caris arrivals continue med-tech IPO hot streak - BioWorld MedTech
Virtual chronic care provider Omada Health raises $150 million in US IPO - MSN
Omada Health Completes Successful Initial Public Offering - TipRanks
Omada Wraps IPO, Raises $150M - Healthcare Innovation
Omada goes public in second recent digital health IPO - BioPharma Dive
Omada Health Shares Soar After IPO as GLP-1 Drugs Fuel Interest - MSN
Finanzdaten der Omada Health Inc-Aktie (OMDA)
Es liegen keine Finanzdaten für Omada Health Inc (OMDA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
4.73%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):